Skip to main content

Tamara Strohm, MD

February 14, 2026
  I am interested in medical student education, neuropalliative care, and clinical pathophysiology of stroke.

Robert J. Eshter, MD, M.Sc.

February 14, 2026
  Musculoskeletal Tumors

Laura Marie Thornton, PhD

February 14, 2026
  Eating disorders Suicide Pediatric obesity

Mallory McClester Brown, MD, AGSF

February 14, 2026
  As a family physician and geriatrician, I am grateful to work alongside and collaborate with an interprofessional team each day. As a residency program director, I role model collaborative care to our future work force. I also aid in the creation and implementation of new curriculum that investigates disparities...

Jesse Raab, PhD

February 14, 2026
  Chromatin regulators are among the most frequent mutations in hepatocellular carcinoma and cholangiocarcinoma. We are interested in how disruption of normal chromatin regulation gives rise to these tumors. We are also looking for new therapeutic strategies targeting the epigenome. We use high throughput CRISPR screens to uncover new therapeutic...

Irena Dujmovic Basuroski, MD, PhD

February 12, 2026
My clinical interests include multiple sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSD), myelin oligodendrocyte antibody associated disease (MOGAD), transverse myelitis (TM), optic neuritis, neurosarcoidosis, autoimmune encephalitis, neurological complications of systemic connective tissue diseases, and other immune-mediated diseases of the central nervous system (CNS). At UNC, I am currently MS/Neuroimmunology Division...

Sasha E. Knowlton, MD

February 12, 2026
  My clinical and research goals focus on improving the quality of life and functional independence for patients with cancer from the time of diagnosis through treatment and into survivorship. I believe in creating a personalized cancer rehabilitation program for each patient in a collaborative manner with a team of...

David C. Williams Jr, MD, PhD

February 12, 2026
  We study epigenetic complexes involved in gene silencing using structural biology and biophysical techniques. The over-arching goal is to develop inhibitors of these complexes as molecular probes and novel therapeutics for blood disorders and cancers. We currently focus on the NuRD complex and its role in fetal hemoglobin regulation.

Erica Sparkenbaugh, PhD

February 12, 2026
  Sickle Cell Disease, hematology, hemoglobinopathies, platelets, thrombosis, hemostasis,

Victoria Boggiano MD, MPH, DipABLM, FAAFP

February 12, 2026
Lifestyle medicine, peripartum care, narrative medicine, primary care transformation research

Donald O. Freytes, PhD

February 12, 2026
  My research focuses on extracellular matrix (ECM) scaffold materials, emphasizing understanding host–biomaterial responses that control inflammation and fibrosis. Specifically, my lab examines how macrophage- and fibroblast-mediated signaling influences scaffold remodeling, immune regulation, and fibrotic outcomes after implantation. A key application of this work is vocal fold regeneration, where we...

Maria E. Ferris, MD, MPH, PhD

February 12, 2026
Dr. Maria Díaz-González de Ferris received her medical doctorate degree from the Universidad Nacional Autónoma de Mexico, a master’s degree in public health as well as a PhD in the field of epidemiology from the University of Texas School of Public Health. She completed her Pediatrics training at Driscoll Children’s...